170 related articles for article (PubMed ID: 37019595)
1. Epigenetic regulation of pluripotency inducer genes NANOG and SOX2 in human prostate cancer.
Niharika ; Roy A; Mishra J; Chakraborty S; Singh SP; Patra SK
Prog Mol Biol Transl Sci; 2023; 197():241-260. PubMed ID: 37019595
[TBL] [Abstract][Full Text] [Related]
2. Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells.
Barrand S; Collas P
Biochem Biophys Res Commun; 2010 Jan; 391(1):762-7. PubMed ID: 19944068
[TBL] [Abstract][Full Text] [Related]
3. Protein arginine methyltransferase 7-mediated
Chen TY; Lee SH; Dhar SS; Lee MG
J Biol Chem; 2018 Mar; 293(11):3925-3936. PubMed ID: 29378844
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of gene expression in porcine epiblast, hypoblast, trophectoderm and epiblast-derived neural progenitor cells.
Gao Y; Jammes H; Rasmussen MA; Oestrup O; Beaujean N; Hall V; Hyttel P
Epigenetics; 2011 Sep; 6(9):1149-61. PubMed ID: 21975513
[TBL] [Abstract][Full Text] [Related]
5. Global and gene-specific histone modification profiles of mouse multipotent adult germline stem cells.
Khromov T; Pantakani DV; Nolte J; Wolf M; Dressel R; Engel W; Zechner U
Mol Hum Reprod; 2011 Mar; 17(3):166-74. PubMed ID: 20935159
[TBL] [Abstract][Full Text] [Related]
6. HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency.
Santoni FA; Guerra J; Luban J
Retrovirology; 2012 Dec; 9():111. PubMed ID: 23253934
[TBL] [Abstract][Full Text] [Related]
7. Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells.
Wang K; Chen Y; Chang EA; Knott JG; Cibelli JB
Cloning Stem Cells; 2009 Dec; 11(4):483-96. PubMed ID: 20025521
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.
Mathews LA; Hurt EM; Zhang X; Farrar WL
Mol Cancer; 2010 Oct; 9():267. PubMed ID: 20929579
[TBL] [Abstract][Full Text] [Related]
9. Promoter-exon relationship of H3 lysine 9, 27, 36 and 79 methylation on pluripotency-associated genes.
Barrand S; Andersen IS; Collas P
Biochem Biophys Res Commun; 2010 Oct; 401(4):611-7. PubMed ID: 20920475
[TBL] [Abstract][Full Text] [Related]
10. NANOG Plays a Hierarchical Role in the Transcription Network Regulating the Pluripotency and Plasticity of Adipose Tissue-Derived Stem Cells.
Pitrone M; Pizzolanti G; Tomasello L; Coppola A; Morini L; Pantuso G; Ficarella R; Guarnotta V; Perrini S; Giorgino F; Giordano C
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545230
[TBL] [Abstract][Full Text] [Related]
11. Histone Modifications on the Promoters of Human OCT4 and NANOG Genes at the Onset of Neural Differentiation of NT2/D1 Cells.
Topalovic V; Schwirtlich M; Stevanovic M; Mojsin M
Biochemistry (Mosc); 2017 Jun; 82(6):715-722. PubMed ID: 28601081
[TBL] [Abstract][Full Text] [Related]
12. BACH1 recruits NANOG and histone H3 lysine 4 methyltransferase MLL/SET1 complexes to regulate enhancer-promoter activity and maintains pluripotency.
Niu C; Wang S; Guo J; Wei X; Jia M; Chen Z; Gong W; Qin Y; Wang X; Zhi X; Lu M; Chen S; Gu M; Zhang J; Han JJ; Lan F; Meng D
Nucleic Acids Res; 2021 Feb; 49(4):1972-1986. PubMed ID: 33503260
[TBL] [Abstract][Full Text] [Related]
13. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.
Kashyap V; Rezende NC; Scotland KB; Shaffer SM; Persson JL; Gudas LJ; Mongan NP
Stem Cells Dev; 2009 Sep; 18(7):1093-108. PubMed ID: 19480567
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional reprogramming and chromatin remodeling accompanies Oct4 and Nanog silencing in mouse trophoblast lineage.
Carey TS; Choi I; Wilson CA; Floer M; Knott JG
Stem Cells Dev; 2014 Feb; 23(3):219-29. PubMed ID: 24059348
[TBL] [Abstract][Full Text] [Related]
16. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.
Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM
J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122
[TBL] [Abstract][Full Text] [Related]
17. CARM1 is required in embryonic stem cells to maintain pluripotency and resist differentiation.
Wu Q; Bruce AW; Jedrusik A; Ellis PD; Andrews RM; Langford CF; Glover DM; Zernicka-Goetz M
Stem Cells; 2009 Nov; 27(11):2637-2645. PubMed ID: 19544422
[TBL] [Abstract][Full Text] [Related]
18. Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions.
Xiao L; Song Y; Huang W; Yang S; Fu J; Feng X; Zhou M
Reprod Biol Endocrinol; 2017 Mar; 15(1):14. PubMed ID: 28253866
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.
Freberg CT; Dahl JA; Timoskainen S; Collas P
Mol Biol Cell; 2007 May; 18(5):1543-53. PubMed ID: 17314394
[TBL] [Abstract][Full Text] [Related]
20. Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.
Farthing CR; Ficz G; Ng RK; Chan CF; Andrews S; Dean W; Hemberger M; Reik W
PLoS Genet; 2008 Jun; 4(6):e1000116. PubMed ID: 18584034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
